Archived Press Releases







Press Releases

8.30.2011

MonoSol Rx Announces Second PharmFilm® Product for ADHD

6.23.2011
MonoSol Rx Aligns Executive Leadership to Maximize Growth Opportunities, Operational Excellence and R&D Pipeline

5.13.2011
Drugs that Melt in Your Mouth: MonoSol Rx Has Its Sights Set on Oral Insulin

4.26.2011
MonoSol Rx and KemPharm to Develop Novel PharmFilm® Product for ADHD

9.13.2010
Warren- based MonoSol Rx Introduces New Methods of Admnistering Medicine

8.31.2010
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone Sublingual Film for Treatment of Opioid Dependence

8.11.2010
Midatech and MonoSol Rx Announce Filing of Joint Patent Application for Nanoparticle File Delivery Systems

7.07.2010
MonoSol Rx Announces FDA Approval of ZuplenzB. Oral Soluble Film for Treatment of Nausea and Vomiting

6.24.2010
MonoSol Rx Expands Collarboration with Midatech to Deliver Peptides Utilizing its PharmFilmB. Drug Delivery Technology

6.21.2010
MonoSol Rx Appoints Dr. Eric Dadey Senior Vice President, Pharmaceutical Development

6.17.2010
MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance

1.05.2010
MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

7.23.2009
MonoSol Rx Appoints Theodore Clemente Vice President Business Development

6.10.2009
MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip

4.09.2009
MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

4.03.2009
MonoSol Rx Granted U.S. Article of Manufacture Patent

3.12.2009
MonoSol Rx Achieves Milestones for Additional $2.5 Million Private Debt Financing

3.12.2009
MonoSol Rx to Present at Cowen & Company 29th Annual Health Care Conference

12.16.2008
MonoSol Rx Enters Agreement with Hikma Pharmaceuticals PLC for Thin Film Pharmaceutical Products in the Middle East

12.02.2008
MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA

11.26.2008
MonoSol Rx to Present at the 20th Annual Piper Jaffray Health Care Conference

11.03.2008
MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies

10.13.2008
Drug-delivery tech firms find bright spot in the economy

9.25.2008
MonoSol Rx Closes $20 Million in Private Equity Financing

9.11.2008
MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process

8.04.2008
MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Bioequivalence Study

6.17.2008
MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical

6.12.2008
MonoSol Rx Closes $10 Million in Private Debt Financing

6.05.2008
MonoSol Rx Names Vincent Viviani Senior Vice President, Manufacturing and Operations

5.28.2008
MonoSol Rx Appoints John McCracken Senior Vice President Business Development

4.15.2008
MonoSol Rx, LLC granted US patent for thin film manufacturing process

2.21.2008
MonoSol Rx, LLC completes thin film ondansetron pilot bioequivalence study

4.02.2007
MonoSol Rx Announces Hiring of Larry W. Kranking as Senior Vice-President, Pharmaceutical Operations

12.12.2006
MonoSolRx Closes $38 Million Preferred Equity Investment

9.22.2006
MonoSolRx to Present at the UBS Global Life Sciences Conference

7.24.2006
MonoSolRx Announces Hiring of Keith Kendall as Chief Financial Officer

7.06.2006
MonoSol Rx Completes Successful DEA Registration of Both Its Manufacturing Facility and Development Facility

6.06.2006
MonoSol Rx Completes Analytical Laboratories to Support Film Based Drug Development and Manufacturing

5.22.2006
MonoSol Rx Announces Legal Settlement With Novartis Consumer Health Relating...